Bristol Myers Squibb (BMY) had its price target raised by HSBC Holdings plc from $53.00 to $60.00. They now have a "hold" rating on the stock.
Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference [Yahoo! Finance]
Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors [Yahoo! Finance]
Dave Schuette Joins DataJoint Board of Directors [Yahoo! Finance]
Defense Lifts Moat Stocks As Tech Stumbles [Seeking Alpha]